Patients with previously treated metastatic pancreatic cancer lived roughly twice as long on a daily oral drug called ...

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how ...

A pancreatic cancer drug more than four decades in the making has cracked one of the most stubbornly lethal cancers, ...

The study showed that an experimental pill from the company Revolution Medicines almost doubled metastatic pancreatic cancer patients’ survival times compared with chemotherapy.

Daraxonrasib, which nearly doubled patients' survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth.

A new pancreatic cancer treatment may finally move the needle on what's proved to be an unforgiving disease. Fred Hutch ...

A promising new pancreatic cancer treatment pill has shown remarkable results, helping advanced patients live significantly ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

The FDA has given some patients early access to the drug, daraxonrasib. A study being presented at an oncology conference in Chicago show it's the first treatment to considerably extend the lives of ...

Clinical trials at Emory and Piedmont are signaling a potential breakthrough in treating pancreatic cancer, one of the nation ...

Former Sen. Ben Sasse of Nebraska reveals an experimental cancer drug helped shrink his tumors by 76% after a stage 4 metastatic pancreatic cancer diagnosis.